<DOC>
	<DOCNO>NCT02413229</DOCNO>
	<brief_summary>The objective study evaluate therapeutic efficacy safety DSXS Placebo patient moderate severe scalp psoriasis .</brief_summary>
	<brief_title>A Randomized Double Blind Vehicle Controlled Dose Ranging Parallel Design Multiple Site Clinical Study</brief_title>
	<detailed_description>This randomize , double-blind , vehicle-controlled , dose-ranging , parallel-group multi-site study design evaluate therapeutic efficacy safety investigational product , DSXS , treatment moderate severe scalp psoriasis different application time 30 minute .</detailed_description>
	<mesh_term>Psoriasis</mesh_term>
	<criteria>Male nonpregnant , nonlactating female age 12 older . Clinical diagnosis moderate severe scalp psoriasis , define Investigator 's Global Assessment score least 3 screen . Under 12 year age . Patients whose scalp and/or nonscalp psoriasis necessitates systemic concomitant topical therapy study . Has scalp skin condition would interfere diagnosis assessment plaque psoriasis scalp .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>